Today's top medical abstracts
Rheumatology
Become a Member Today!
Email
Password
Remember me
Forgot your Password?

Invite Code?

Home
General Rheumatology
For Practicing
Rheumatologists
Conferences
Jobs
Newsletters
My Library
Topics in
Rheumatology
        Amyloidosis
        Autoimmune/Heritable
        Basic Science/Genetics
        Bone Metabolism
        Chr Fatigue/Fibromyalgia
        Clinical Pharmacology
        Connective Tissue Dz
        Diagnostics/Radiology
        Economics of Medicine
        Gout and Hyperuricemia
        Infectious Arthritis
        Osteoarthritis
        Other Arthritis
        Pediatric Rheumatology
        Popular Press
        Rheumatoid Arthritis
        Spondylarthropathies
        Systemic Lupus (SLE)
        Vasculitic Syndromes
 
Help
Resource Center
RSS News Feeds
Send Newsletter
to a Friend
 
Sponsor
For Practicing Rheumatologists
Today's Rheumatology News: VGX-1027 To Undergo Additional Testing For RA
D Scott Cunningham MD, PhD, MDLinx Rheumatology
Today's Rheumatology News: FDA Approves Actemra
D Scott Cunningham MD, PhD, MDLinx Rheumatology
From the Editors: New Clinical-Only Option for MDLinx!
Stephen Smith, MDLinx
  See all
hip osteoarthritis;type II collagen biomarkers Article Summary

Click the title below to leave the MDLinx Network and go to the Journal's Website
Serum concentrations of type II collagen biomarkers (C2C, C1, 2C and CPII) suggest different pathophysiologies in patients with hip osteoarthritis
Clinical and Experimental Rheumatology Online, 07/02/08
Print     Email This Article     Save in My Library   Free Abstract
Conrozier T et al. – Hip OA, in patients with multiple sites OA (MSOA), might be related to alteration in type II collagen (CII) metabolism which may result in a deficient type II collagen repair process.

Methods
  • Study to determine whether there are detectable differences in and relationships between biomarkers of CII degradation and synthesis in pts with only hip OA (OHOA) and those suffering from MSOA
  • 56 pts classified as MSOA or OHOA
  • Minimum hip joint space width (Min JSW) measured by computer from standard radiographs
  • Serum measurement of CII synthesis C-propeptide (CPII) and cleavage of type II (C2C) and types I and II (C1, 2C) collagens
  • Aggrecan metabolism was assessed by serum CS 846 assay

Results
  • 24 subjects were classified with MSOA
  • 15/32 OHAO pts had bilateral hip OA and 17 had unilateral hip OA
  • The latter were classified with “Isolated hip OA” (IHOA)
  • CPII levels were lower in pts with MSOA vs those with OHOA
  • C2C levels were also lower in MSOA vs OHOA
  • An inverse correlation between min JSW and C2C only in pts with IHOA

Read a Different Specialty
Allergy/Immunology
Anesthesiology
Cardiology
Dermatology
Drugs
Emergency Medicine
Endocrinology
ENT
Family Medicine
Gastroenterology
Hematology-Oncology
Infectious Disease
Internal Medicine
Nephrology
Neurology
OB/Gyn
Ophthalmology
Orthopedics
Pediatrics
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology
Profession Index
Dentist
Hospital Administrator
Nurse
    Medical Students
Nurse Practitioner
Pharma/Drug Marketer
    Pharmacist
Physician
Physician Assistants
Article Search
Keyword:
Search:
Published within:
Sort By:
Date Relevance
    
Sponsor
About MDLinx  |  Contact  |  Advertise with MDLinx  |  Site Map  |  Privacy Policy  |  Terms of Use  |  Sign Up For Newsletters  |  Recommend this Site

English |  Español |  Français |  Deutsch |  中文 |  Руccкий |  Norsk |  Nederlands |  Português |  Italiano

©1999-2008 MDLinx, Inc.